Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam and Butorphanol for Painless Gastrointestinal Endoscopy in Obese Patients
ChiCTR2500104455Phase 4Not yet recruiting
- Sponsor
- Anesthesia and Surgery Center of 363 Hospital
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam (3 arms), sponsored by Anesthesia and Surgery Center of 363 Hospital. Primary endpoints: Level of sedation recovery and Incidence of adverse events. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2500104455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500104455.